Filter
2304
Filtered Results: 2304
Text search:
controlled
drugs
Featured
Recommendations
264
New Publications
513
Language
Document type
No document type
1341
Guidelines
400
Studies & Reports
312
Manuals
117
Strategic & Response Plan
62
Fact sheets
32
Training Material
26
Situation Updates
6
Brochures
4
Resource Platforms
2
Infographics
2
Countries / Regions
India
171
Kenya
65
Global
63
South Africa
56
Western and Central Europe
46
Uganda
43
Ethiopia
40
Nigeria
38
Tanzania
34
Sierra Leone
33
Latin America and the Carribbean
32
Africa
31
Zambia
30
Nepal
29
Malawi
28
Ukraine
28
Ghana
26
Eastern Europe
26
Liberia
23
Rwanda
23
Philippines
22
Myanmar / Burma
22
Zimbabwe
20
Bangladesh
19
Colombia
17
Russia
17
Brazil
16
Syria
15
Indonesia
15
South–East Asia Region
15
Lesotho
14
Asia
13
South Sudan
12
Mozambique
11
Namibia
11
Eswatini/ Swaziland
11
Burkina Faso
10
Senegal
9
Argentina
9
Congo, Democratic Republic of
8
Botswana
8
Guinea
7
Cameroon
7
Germany
7
East and Southern Africa
7
Paraguay
7
Venezuela
7
Afghanistan
6
Yemen
6
Haiti
5
Lebanon
5
Thailand
5
Sudan
5
Bolivia
5
Eastern Europe and Central Asia
5
Tajikistan
5
Mali
4
USA
4
Iraq
4
Jordan
4
Chile
4
West and Central Africa
4
Middle East and North Africa
4
North America
4
Somalia
3
Pakistan
3
Cambodia
3
Central African Republic
3
Peru
3
Angola
3
Madagascar
3
Moldova
3
Iran
3
Georgia
3
Guinea-Bissau
2
Morocco
2
Saudi Arabia
2
Egypt
2
China
2
Benin
2
North Macedonia
2
Hungary
2
Ecuador
2
Libya
2
Mexico
2
Bhutan
2
Palestine
2
Albania
2
Laos
2
Canada
2
Lithuania
2
Kyrgyzstan
2
Vietnam
2
Jamaica
2
Côte d’Ivoire / Ivory Coast
1
Turkey
1
Singapore
1
Papua New Guinea
1
Serbia
1
Burundi
1
Greece
1
Sri Lanka
1
Western Pacific Region
1
Poland
1
Djibouti
1
Armenia
1
Timor Leste/ East Timor
1
Qatar
1
Romania
1
Australia
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
819
Clinical Guidelines
321
Public Health
156
Women & Child Health
105
Key Resources
55
Pharmacy & Technologies
29
Capacity Building
26
Protection & Security
1
Toolboxes
Mental Health
292
HIV
222
TB
205
COVID-19
113
AMR
90
Pharmacy
88
NCDs
87
NTDs
67
Caregiver
57
Rapid Response
49
Ebola
45
Conflict
35
Refugee
26
Disability
22
Planetary Health
21
Cholera
14
Global Health Education
14
Natural Hazards
13
Polio
10
Specific Hazards
6
Health Financing Toolbox
6
Zika
5
Social Ethics
2
This guide provides national stakeholders and advocates with information and guidance to update the national essential medicines list to include a new commodity, a new indication, or a new formulation based on the available evidence and based on country need and disease burden. While the actors, tim...
Mental Health First Aid Guidelines
Accessed: 14.03.2019
This block contains a wide variety of disorders that differ in severity (from uncomplicated intoxication and harmful use to obvious psychotic disorders and dementia), but that are all attributable to the use of one or more psychoactive substances (which may or may not have been medically prescribed)
Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach model of service delivery?
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials...
SCOPING QUESTION: In the management of prescription opioid dependence, does supervised dosing with a long-acting opioid medication result in less opioid use and related harms than non-prescription, detoxification or usual care?
AIDS Research and Therapy 2015, 12:12 (24 April 2015)
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder
Accessed: 14.03.2019
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by the public in African Union Member States.
Currently...
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start treatment. According to the WHO, the move to early ...
